TrialThe Lancet. Infectious diseases2023

Safety and immunogenicity of a purified inactivated Zika virus vaccine candidate in adults primed with a Japanese encephalitis virus or yellow fever virus vaccine in the USA: a phase 1, randomised, double-blind, placebo-controlled clinical trial.

Michael A Koren et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.